Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BMI
BMI logo

BMI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Badger Meter Inc (BMI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
135.500
1 Day change
0.63%
52 Week Range
252.530
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Badger Meter Inc (BMI) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock faces significant negative catalysts, including lawsuits, declining revenue, and negative sentiment from analysts. While the technical indicators suggest a neutral to slightly positive trend, the lack of strong proprietary trading signals and the absence of positive financial or news-driven catalysts make it prudent to hold off on investing in this stock.

Technical Analysis

The MACD histogram is positive at 1.173, indicating a slight bullish momentum, but it is contracting. RSI is at 74.095, which is in the neutral zone, suggesting no clear overbought or oversold conditions. Moving averages are converging, and the stock is trading near its resistance level of R2: 139.674. Overall, the technical indicators are neutral with no strong buy signals.

Options Data

Neutral
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
8

Positive Catalysts

  • NULL identified.

Neutral/Negative Catalysts

  • The company is facing a class action lawsuit for alleged financial misrepresentation, which has significantly impacted investor confidence. Revenue has declined by 9% year-over-year, and the stock has dropped over 24%. Analysts have downgraded the stock and lowered price targets, citing underwhelming performance and muted growth outlook. Additionally, there is no recent congress trading data or insider buying activity to suggest confidence in the stock.

Financial Performance

No financial data available for the latest quarter. However, news indicates a 9% year-over-year revenue decline and underwhelming Q1 performance.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have downgraded the stock and lowered price targets. Maxim downgraded BMI to Hold, citing overly optimistic growth guidance. RBC Capital, Baird, Barclays, and JPMorgan have all reduced price targets, with Barclays maintaining an Underweight rating and citing expensive valuation relative to muted growth prospects.

Wall Street analysts forecast BMI stock price to rise
7 Analyst Rating
Wall Street analysts forecast BMI stock price to rise
5 Buy
1 Hold
1 Sell
Moderate Buy
Current: 134.650
sliders
Low
157
Averages
214.86
High
243
Current: 134.650
sliders
Low
157
Averages
214.86
High
243
Maxim
Buy
to
Hold
downgrade
AI Analysis
2026-04-23
Reason
Maxim
Price Target
AI Analysis
2026-04-23
downgrade
Buy
to
Hold
Reason
As previously reported, Maxim downgraded Badger Meter to Hold from Buy. The company's 2026 organic growth guidance of flat seems optimistic based on its Q1 results and Q2 outlook as it implies at least 7%-9% growth in the second half of the year, the analyst tells investors in a research note. Maxim adds it is cutting its 2026 EPS view to $4.39 from $5.32.
Maxim
Tate Sullivan
Buy
to
Hold
downgrade
2026-04-23
Reason
Maxim
Tate Sullivan
Price Target
2026-04-23
downgrade
Buy
to
Hold
Reason
Maxim analyst Tate Sullivan downgraded Badger Meter to Hold from Buy.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BMI
Unlock Now

People Also Watch